Category : Most Popular

Wedbush analyst James Hardiman upgraded Polaris to Outperform from Neutral with a price target of $106, up from $68. The stock closed Thursday down $2.06...

Ralph Lauren Corp (NYSE:RL) saw its shares gain traction Wednesday morning on the newest earnings figures. The New York-based fashion giant reported earnings per diluted...

Regeneron Pharmaceuticals (REGN) announced the commencement of an underwritten public secondary offering of its common stock through which Sanofi (SNY) intends to exit its investment...

Another casualty of the COVID-19 pandemic; Canadian retail sales took their biggest one-month spill ever during March. Figures released Friday by Statistics Canada revealed that...

Netflix said in a blog post: "At Netflix, the last thing we want is people paying for something they're not using. So we're asking everyone...

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to Hold from Buy at Loop...

Piper Sandler analyst Edward Tenthoff raised the firm's price target on Moderna to $102 from $57 and reiterates an Overweight rating on the shares. The...

Barry Rosenstein's Jana Partners disclosed in a regulatory filing its holdings as of March 31, 2020. Jana made two new buys during the first quarter:...

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SmileDirectClub (SDC) double downgraded to Underperform from Buy at...

JPMorgan analyst Cory Kasimov keeps a Neutral rating on Gilead Sciences with an $85 price target after hosting a call with CFO Andy Dickenson and...